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Abstract
Background: Impairment in glomerular endothelial function likely plays a major role in the development of
albuminuria and CKD progression. Glomerular endothelial dysfunction may reflect systemic microvascular
dysfunction, accounting in part for the greater cardiovascular risk in patients with albuminuria. Prior studies of
vascular function in CKD have focused on conduit artery function or those with ESRD, and have not examined
microvascular endothelial function with albuminuria.
Methods: We conducted a cross-sectional study among older hypertensive male veterans with stage 1–4 CKD, and
hypertensive controls without CKD. Microvascular function was quantified by two distinct Laser-Doppler flowmetry
(LDF) measures: peak responses to 1) post-occlusive reactive hyperemia (PORH) and 2) thermal hyperemia (TH),
measured on forearm skin. Associations of each LDF measure with albuminuria, eGFR, and CKD status were
estimated using correlation coefficients and multiple linear regression, accounting for potential confounders.
Results: Among 66 participants (mean age 69.2 years), 36 had CKD (mean eGFR 46.1 cc/min/1.73 m2; 30.6 % with
overt albuminuria). LDF responses to PORH and TH were 43 and 39 % significantly lower in multivariate analyses
among those with macroalbuminuria compared to normoalbuminuria, (β= − 0.42, p = 0.009 and β= −0.37, p = 0.01,
respectively). Those with CKD had a 23.9 % lower response to PORH compared to controls (p = 0.02 after
adjustment). In contrast, TH responses did not differ between those with and without CKD.
Conclusions: Microvascular endothelial function was strongly associated with greater albuminuria and CKD,
independent of diabetes and blood pressure. These findings may explain in part the excess systemic cardiovascular
risk associated with albuminuria and CKD.
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Background
The risk of cardiovascular related morbidity and mortality
in individuals with chronic kidney disease (CKD) is exceed-
ingly high and often greater than the risk of progressing to
end-stage renal disease (ESRD), especially in older adults
[1]. However, the mechanisms which account for the sys-
tematic vascular manifestations of albuminuria and CKD
are not fully elucidated. The endothelium, a single cell layer
providing the interface between circulating blood and the
vascular wall, regulates many critical aspects of vascular
function including vascular tone, coagulation, and protec-
tion against oxidative stress and inflammation [2]. It has
been proposed that elevated urine albumin excretion-
especially low to moderate elevations - represents a state of
generalized endothelial dysfunction, but there has been
relatively limited direct evidence in humans to support this
hypothesis [3]. Moreover, dysfunction of the endothelium is
increasingly recognized as a sentinel event in the develop-
ment and progression of both focal and systemic vascular
disease. Indeed, markers and measures of endothelial dys-
function, a determinant of systemic vasculopathy, have
been shown to be increased in CKD [4]. However, a variety
of endothelial function measures have been employed, each
with advantages and weaknesses. Most prior studies
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examining endothelial function have focused on ischemic
flow mediated dilatation (FMD) of medium sized conduit
arteries such as the brachial artery. These studies have dem-
onstrated a significant impairment in the endothelium-
dependent vasodilatation of the brachial artery among pa-
tients with ESRD, late stage CKD, or patients with glomer-
ulonephritis, compared to controls [5–9]. Although such
conduit artery function represents an important potential
mediator of vascular risk, the renal vascular bed consists
predominately of micro-vessels. Therefore, dysfunction of
the microvascular endothelium may better characterize the
systemic vasculopathy of CKD [10, 11]. Studies of endothe-
lial function and albuminuria have been less consistent, in
the context of variable methodological approaches and
populations and have not focused on albuminuria in pa-
tients with HTN with and without moderate CKD [8, 12–
15]. Non-invasive evaluation of the cutaneous microcircula-
tory is readily feasible using the technique of Laser- Dop-
pler flowmetry (LDF). Specifically, the semi-automated use
of LDF to measure cutaneous microcirculatory function in
response to specific provocations has been advocated as a
practical and reliable in-vivo assay of systemic microvascu-
lar vasodilatory function [16, 17]. A small number of prior
studies using LDF techniques have demonstrated deficits in
endothelium-dependent microvascular function in patients
with ESRD and advanced non-dialysis dependent CKD
compared to controls, and an association of these func-
tional measures with cardiovascular risk [10, 18–20]. How-
ever, it is unclear whether microvascular endothelial
dysfunction is present among those with earlier stages of
CKD, and whether common comorbidities in those with
CKD such as hypertension and diabetes account for this
dysfunction.
We therefore performed an observational, cross-
sectional study to examine the relationship of micro-
vascular endothelial function with non-dialysis CKD and
measures of renal disease severity (albuminuria and
eGFR) among older adults with treated hypertension.
We hypothesized that those older adults with greater al-
buminuria and lower eGFR would have more diminished
endothelial function as assessed by two separate laser
Doppler flowmetry based measures, after accounting for
demographic and co-morbid factors.
Methods
Study subjects
Community-dwelling hypertensive outpatients at the VA
Maryland Healthcare System aged 60 or older with and
without chronic kidney disease (stages 1–4) or diabetes
mellitus were eligible for participation. CKD was defined
according to K/DOQI criteria as persistent eGFR < 60 cc/
min/1.73 m2 or abnormal albuminuria for at least
3 months. Patients with any of the following conditions
were excluded from participation: NYHA class III-IV
heart failure; coronary revascularization or acute cor-
onary syndrome within the prior 3 months; vascular
claudication; prior stroke; dementia; severe anemia
(Hb < 9 g/dL), and poorly controlled hypertension
(BP > 180/95) or diabetes (HbA1C > 11 %). Partici-
pants were recruited from nephrology, diabetes, and
primary care clinics. Participants were enrolled con-
secutively from 11/2010 through 2/2013, without spe-
cific matching of CKD and non-CKD patients.
Covariates and measurements
Clinical co-morbidity was determined through review of
the electronic medical record and participant interview.
Coronary artery disease was defined as a history of prior
myocardial infarction, coronary revascularization, and/or
coronary disease by angiography. Albuminuria was
quantified with the urine albumin/creatinine ratio on a
spot morning urine sample after an overnight fast. Albu-
minuria was classified as per standard criteria as nor-
moalbuminuria if albumin/creatinine ratio < 30 mg/gm;
microabluminuria if albumin/creatinine ratio was 30 to
300 mg/gm and macroalbuminuria if albumin/creatinine
ratio was > 300 mg/gm. Blood pressure was recorded in
the sitting position prior to LDF measurements using a
Critikon Dinamap 1846 SX monitor (GE Medical Sys-
tems), and mean arterial pressure calculated as (DBP +
(SBP-DBP)/3). GFR was estimated from serum
creatinine measured with an IDMS-traceable assay using
the 4-variable MDRD equation.
Laser Doppler flowmetry (LDF)
LDF uses a laser light source and Doppler shift effect to
non-invasively measure microvascular blood flow on a
relative BPU (Blood Perfusion Units) scale. This allows
for the measurement of relative change in microcircula-
tory perfusion in response to various interventions. All
measurements were performed according to a standard-
ized protocol with a Perimed, PF5020 unit in a
temperature-controlled room after an overnight fast and
after withholding of AM doses of vasoactive medications
including nitrates. Active smokers were instructed to ab-
stain from smoking the day of LDF testing. We used two
distinct LDF based measures: 1) post occlusive reactive
hyperemic (PORH) and 2) thermal hyperemic (TH) me-
diated response. In TH-LDF, the LDF probe is placed on
the volar aspect of the forearm and heated to 44C caus-
ing dilatation of the skin vessels and increased flow,
which is measured over 30 min. TH-LDF results in a bi-
phasic response, an initial axon reflex peak phase which
is mediated in part by the neuropeptides substance P
and calcitonin gene-related peptide (CGRP). This is
followed by a more prolonged plateau phase, largely me-
diated by the endothelial release of nitric oxide [21]. For
PORH-LDF, the upper arm flow is occluded by a blood
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pressure cuff for a 4-min period. The resultant ischemia
induces dilatation of resistance vessels. Upon release of
the cuff, there is a rush of blood flow secondary to the
induced decreased arterial resistance, which in turn
causes increase shear stress on the vessels, inducing fur-
ther dilatation by endothelial and potentially non-
endothelial based mediators. All blood flow tracings
were digitally transferred and interpreted by a single re-
viewer (AS) blinded to clinical characteristics of the par-
ticipant. Tracings with technical deficiencies precluding
accurate quantification (eg participant motion, displace-
ment of probe during recording) were excluded from
analysis. The percent increase in flow from baseline is
then used as a measure of endothelial function and vas-
cular reactivity for both TH and PORH-LDF measures
[21]. Additionally, PORH- and TH-LDF were catego-
rized as high or low, if above or below the median for
each measure, respectively.
Statistical methods
Clinical characteristics between those with and without
CKD were compared using the independent-sample t-tests
for continuous variables and chi-squared or Fisher’s exact
test for categorical variables. Comparisons of each LDF
measure across albuminuria category were performed with
ANOVA tests. Correlations of each LDF measure (response
to TH and PORH) with albuminuria were estimated using
Pearson correlation coefficients, after natural logarithm (ln-
transformation) of the urine albumin/creatinine ratio to en-
sure a normal distribution. The association of albuminuria
and CKD with each LDF measure (dependent variable) after
adjusting for demographic and co-morbid factors was esti-
mated using multiple linear regression. Adjustment covari-
ates were selected a priori and included age, self-reported
race (African-American vs. other), mean arterial pressure,
coronary artery disease, and diabetes. Associations were pre-
sented as standardized regression coefficients ( β^ ) to allow
comparison across different outcome measurements. The
Cook-Weisberg test was used to confirm the assumption of
homoscedasticity.
Results
Cutaneous PORH and/or TH provocations measures were
obtained on 66 male participants. Of these, 61 PORH and
52 TH tracing were determined to be of sufficient technical
quality for quantification of peak response. Compared to
those without CKD (N = 30), those with CKD (N = 36) were
overall well matched with similar age, race, blood pressure,
body mass index, use of renin-angiotensin antagonists, and
smoking history, but were more likely to have diabetes (p <
0.01) (Table 1.) Of those with CKD, 11 (30.6 %) had overt
albuminuria, with mean (SD) eGFRMDRD 46.1 (2.4) cc/min/
1.73 m2; 4 (11 %) had stage 2, 28 (78 %) had stage 3, and 4
(11 %) had stage 4 CKD.
PORH-LDF
Comparing those with high vs. low PORH-LDF, those with
lower post-occlusive microvascular reactivity had modestly
lower systolic blood pressure and significantly lower eGFR
and higher albuminuria (Table 2.) In univariate analysis,
PORH-LDF was 43 % lower among those with macroalbu-
minuria compared to those with normoalbuminuria (Fig. 1a;
95 % CI = 0.10 to 0.90 %, p = 0.03) and was inversely corre-
lated with albuminuria (r = −0.31, p = 0.01) (Fig. 2a). After
adjustment for demographic factors, blood pressure and
diabetes, PORH-LDF remained inversely associated with
greater albuminuria (Table 3; β^= − 0.37, 95 % CI = −0.55 to
−0.08, p = 0.01.) The association between PORH and albu-
minuria did not differ with diabetic status (all tests of inter-
action, p > 0.5). eGFR as a continuous variable was not
associated with PORH-LDF measures (p = 0.2.) Among
those with CKD, PORH-LDF response was 24%lower com-
pared to non-CKD controls (Fig. 3a: 95 % CI = −0.61 % to
−0.05 %, p = 0.045). After multivariate adjustment, this as-
sociation remained significant (Table 3; β^= − 0.38, 95 % CI
= −0.62 to −0.01, p = 0.02).
TH-LDF
Consistent with our PORH-LDF based results, those with
lower TH reactivity had higher albuminuria (Table 2; p =
0.009). Albuminuria was inversely and strongly correlated
with TH-LDF (Fig. 2b:r = −0.41, p = 0.003.) TH-LDF
Table 1 Baseline characteristics of study sample
No CKD (N = 30) CKD (N = 36) p-value
Age 68.6 (1.4) 69.7 (1.2) 0.5
African American 18 (60 %) 18 (50 %) 0.7
SBP (mmHg) 137.6 (19.2) 143.1 (16.6) 0.2
DBP (mmHg) 74.0 (10.5) 74.8 (8.7) 0.7
BMI 30.4 (5.5) 31.0 (6.3) 0.7
Diabetes 6 (20 %) 27 (75.0 %) <0.01
Coronary Artery Diseasea 2 (6.7 %) 8 (22.2 %) 0.1
Smoking
Current 0 (0 %) 1 (2.8 %) 0.5
Former 21 (70 %) 21 (58.3 %)
Never 9 (30 %) 13 (36 %)
ACEI or ARB 20 (67 %) 28 (77.8 %) 0.3
Nitrates 0 2 0.3
eGFR (cc/min/1.73 m2) 85.4 (19.2) 46.1 (2.4)
Alb/Cr ratio 3.8 [2.9, 7.8] 83.3 [16.6, 367.0]
Cell values represent mean (SD), median [inter-quartile range], and N(%)
aPatients with unstable coronary disease or with recent coronary intervention
were excluded
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measures were 39 % lower among those with macroalbu-
minuria compared to normoalbuminuria (Fig. 1b; p =
0.03.) After adjustment for demographic factors, and
major co-morbidities, greater albuminuria was associated
with lower TH-LDF measures (Table 3.) Of note, the asso-
ciation of TH-LDF measures with albuminuria (β^= − 0.42)
was markedly greater than the associations of age (β=0.15)
and mean arterial pressure (β=0.08).
In contrast with PORH-LDF, there was no significant as-
sociation of CKD or eGFR with TH-LDF based measures
(Fig. 3b and Table 3; p = 0.6 and p = 0.9, respectively.)
The relationship between LDF responses with albu-
minuria did not differ between those with and without
diabetes in either PORH- or TH-LDF (p > 0.5).
Discussion
Among older hypertensive men with and without
non-dialysis dependent CKD, microvascular endothe-
lial function as estimated by the cutaneous hyperemic
response to brachial artery occlusion and localized
heating is decreased in a graded, dose-dependent
fashion with greater albuminuria. Furthermore, those
with CKD had a 24 % lower PORH response than
those without CKD. These associations were robust
to adjustment for selected potential confounders in-
cluding blood pressure, and were qualitatively greater
than the associations of other factors such as greater
age and blood pressure.
Even low-level elevations of albuminuria are associated
with measureable increases in risk of vascular disease, in-
cluding myocardial infarction, stroke, cardiovascular death,
and cognitive decline, especially in older adults. While podo-
cyte function has long been recognized as a key component
of the glomerular albumin barrier, there has been continued
evidence demonstrating that not all proteinuria can be
accounted for based on podocyte dysfunction, such as in
early diabetic nephropathy and systemic inflammatory states
(eg, sepsis and inflammatory bowel disease). Recent evi-
dence strongly suggests a prominent role for the glomerular
endothelial layer and associated glycocalyx as a key barrier
to albumin across the glomerular basement membrane [22].
This finding would potentially account in part for the strong
association between albuminuria and cardiovascular disease
risk, independent of decreased GFR. The results of this
study provide support for this hypothesis, suggesting that –
at least in older adults with hypertension – microvascular
endothelial function is a major correlate of albuminuria, in-
dependent of blood pressure, diabetes and decreased GFR.
Prior studies using LDF to measure microvascular
function in CKD patients have primarily focused on
those with ESRD [10, 11, 18, 20, 23], whether dialysis-
dependent or recipients of renal transplants. These
studies have generally reported significantly lower endo-
thelial function in ESRD or advanced CKD patients
[19] compared to controls, although there have been
discrepant results regarding whether these differences
are independent of hypertension [18]. Prior studies in
Table 2 Characteristics of study sample, by Post-Occlusive and Thermal Hyperemic categories
Post-Occlusive Reactive Hyperemia(N = 65) Thermal Hyperemia (N = 52)
High Low p-value High (>892 %) Low (<892 %) p-value
Age 68.6 70.6 (7.6) 0.3 68.5 (7.3) 69.8 (1.5) 0.5
African American 15 (48.4 %) 17 (56.7 %) 0.5 17 (65.4 %) 12 (46.2 %) 0.2
SBP (mmHg) 145.5 (15.0) 136.0 (18.3) 0.03 141.3 (16.0) 137.2 (18.8) 0.4
DBP (mmHg) 76.5 (10.0) 72.1 (8.1) 0.06 75.4 (10.2) 73.2 (8.1) 0.4
BMI 30.7 (6.6) 30.4 (5.5) 0.9 30.2 (6.3) 32.6 (4.8) 0.14
Diabetes 13 (41.9 %) 18 (60 %) 0.2 16 (61.5 %) 10 (38.5 %) 0.10
Coronary Artery Diseasea 5 (16.1 %) 5 (16.7 %) 1.0 4 (15.4 %) 4 (15.4 %) 1.0
Smoking 0.6
Current 19 (61.3 %) 19 (63.3 %) 0.6 1 (3.9 %) 0 (0 %)
Former 0 (0 %) 1 (3.3 %) 15 (57.7 %) 17 (65.4 %)
10 (38.5 %) 9 (34.6 %)Never 12 (38.7 %) 9(30 %)
ACEI or ARB 19 (63.3 %) 26 (83.9 %) 0.07 18 (69 %) 18 (69 %) 1.0
Nitrates 1 (3.3 %) 1 (3.3 %) 0.8 1 (3.9 %) 0 0.5
eGFR (cc/min/1.73 m2) 69.2 (4.9) 56.0 (4.1) 0.04 61.9 (24.0) 68.7 (29.8) 0.4
Alb/Cr ratio 5 [2.3, 26] 18.2 0.006 4.4 21.5 0.009
[7.2, 334] [2.8, 11.8] [4.4, 207]
Cell values represent mean (SD), median [inter-quartile range], and N (%)
aPatients with unstable coronary disease or with recent coronary intervention were excluded
Seliger et al. BMC Nephrology  (2016) 17:82 Page 4 of 8
ESRD have also suggested that these measures are
prognostically important for short-term prediction of
cardiovascular events in dialysis-dependent patients
[11] and for allograft failure in renal transplant recipi-
ents [23]. Moreover, since various measures of endo-
thelial function and vascular reactivity are only
modestly correlated to each other as they capture
various components of endothelial and vascular re-
sponse [21], we used two methods, TH and PORH to
better ascertain microvascular responses. This allowed
us to estimate the association between CKD and
PORH, which may have been missed by using only
TH based measures, extending previous findings of
reduced microvascular endothelial function to those
with mild-moderate CKD. Lastly, by comparing CKD
patients to age matched controls with hypertension,
as opposed to healthy controls without any co-
morbidity, our findings suggest that the endothelial
functional impairment is not explained merely by the
increased prevalence of hypertension in CKD or
diabetes.
Previous studies of brachial FMD and/or LDF based mea-
sures of vascular and endothelial function have yielded con-
flicting results regarding associations with proteinuria.
Most notably, many of these were in patients with diabetes
and did not explore association between endothelial func-
tion measures and proteinuria, independent of diabetes sta-
tus. Several involved patients with non-diabetic and non-
hypertensive glomerulonephritis or patients with HIV,
which cannot be generalized to the patient with
hypertension-attributed CKD. Our findings of strong con-
sistent dose dependent association between two distinct
measures of microvascular endothelial function and reactiv-
ity, independent of blood pressure and diabetes, meaning-
fully extend previous findings. Moreover, while obtaining
reliable brachial artery FMD measures can be technically
challenging and costly [24], the semi-automated LDF based
TH and PORH measures of skin microvascular reactivity
require minimal training, are relatively easy to obtain and
have good reproducibility and may at times be preferred
over other non-invasive measures of endothelial function
and vascular reactivity [25–27]. Furthermore, LDF
Fig. 1 Hyperemic response to post-occlusive (a) and thermal (b) provocations, by albuminuria category
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measures are considered to be less dependent on systemic
arterial blood pressure, as they reflect blood flow differ-
ence in the microcirculatory vessels, which are not subject
to the high pressure in conduit vessels such as the brachial
artery, and further represent difference in flow from the
baseline, which would normalize any BP-related difference
in baseline blood flow.
Limitations of the present study include the modest
sample size, which precluded extensive subgroup ana-
lysis and limited the potential number of confounders
Fig. 2 Association of hyperemic response to post-occlusive (a) and (b) thermal provocations with albuminuria
Table 3 Association (β^) of microvascular endothelial function with CKD, albuminuria, and eGFR
Post-Occlusive Hyperemia (N = 61) Thermal Hyperemia (N = 52)
Unadjusted Adjusted Unadjusted Adjusted
Albuminuria −0.31 (p = 0.01) −0.37 (p = 0.01) −0.41 (p = 0.003) −0.42 (p = 0.009)
CKD (vs. no CKD control) −0.25 (p = −0.045) −0.38 (p = 0.02) −0.08 (p = 0.6) 0.09 (p = 0.6)
eGFR 0.17 (p = 0.2) 0.20 (p = 0.2) 0.12 (p = 0.41) −0.02 (p = 0.9)
Albuminuria: Natural log- transformed Urine albumin to creatinine ratio, Cell values represent standardized regression coefficient
Adjusted for age, race (African-American vs. other), mean arterial blood pressure, diabetes, and coronary artery disease
Seliger et al. BMC Nephrology  (2016) 17:82 Page 6 of 8
that could be considered in multivariate models. Al-
though those without CKD were of similar age, ethnic
background, and blood pressure to those with CKD,
they were considerably less likely to have diabetes
and stable coronary heart disease. Although we ad-
justed for these differences in regression models, re-
sidual confounding may have persisted. The study
population consisted of older men-consistent with the
recruitment setting of a VA medical center – and the
results may not apply to women or middle-aged
adults. Due to the cross-sectional design of the study,
we cannot determine whether microvascular dysfunc-
tion is a causal factor for albuminuria and CKD, or a
result of the renal disease.
Conclusions
In conclusion, we find that LDF-based measures of
endothelial function and microvascular reactivity are
the strongest determinants of albuminuria in our
older hypertensive population of patients with and
without CKD, irrespective of diabetes status. We also
found our patients with CKD to have lower micro-
vascular reactivity based on our PORH measures.
These findings highlight that skin measures of micro-
vasculatory endothelial function and reactivity as a
proxy of systemic endothelial function are strongly
correlated with albuminuria and that albuminuria may
plausibly reflect glomerular microvasculatory dysfunc-
tion. This provides further evidence in favor of the
Fig. 3 Hyperemic response to post-occlusive (a) and thermal (b) provocations, by albuminuria category, among those with and without CKD
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hypothesis that endothelial function comprises a com-
mon pathophysiology linking renal dysfunction and
albuminuria with systemic vascular disease.
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